Dean Heller bought Bristol-Myers Squibb Company (NYSE: BMY)
Dean Heller (R-NV), a U.S. Senator, has disclosed 4 trades in Bristol-Myers Squibb Company (BMY) since 2018, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Dean Heller bought $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on November 9, 2018. Since that trade, BMY is up +35.72% against the S&P 500 up +204.54%, an outperformance of -168.82%.
Across these filings, Dean Heller has been a balanced trader of BMY (a buy-to-sell ratio of 1.00). The most recent disclosed BMY transaction shown was dated December 6, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Dean Heller's BMY trades vs the price
BMY is up +35.72% since Dean Heller bought on November 9, 2018, versus +204.54% for the S&P 500.
Performance since this trade
All Dean Heller BMY trades
Dean Heller & BMY trading FAQ
Is it legal for Dean Heller to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Dean Heller buy BMY?
Dean Heller disclosed a purchase of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on November 9, 2018, according to public STOCK Act filings.
How has BMY performed since Dean Heller's trade?
Since Dean Heller bought BMY on November 9, 2018, the stock is up +35.72%, versus +204.54% for the S&P 500 over the same period, an outperformance of -168.82%.
How many times has Dean Heller traded BMY?
Dean Heller has disclosed 4 BMY trades since 2018 (2 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
BullishWhales tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
Dean Heller's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyDean Heller's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.